Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
MD Anderson Cancer Center
Dec 6, 2023, 15:06 |
Blog
Ishwaria Subbiah: Become a complex-failure preventer!
Ishwaria Subbiah shared the following on LinkedIn: “Reflecting on my Thanksgiving reading, Dr. Amy Edmondson's…
Dec 6, 2023, 11:43 |
Insight
Vivek Subbiah: Excited and honored to attend the San Antonio Breast Conference meeting
Vivek Subbiah shared on LinkedIn: "Excited and honored to attend the San Antonio Breast Conference…
Dec 5, 2023, 18:49 |
Blog
Anirban Maitra: This was Cullen’s baby from the very preclinical inception in his lab
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at the University of Texas MD…
Dec 4, 2023, 15:54 |
Blog
Vivek Subbiah: Tissue-agnostic precision medicine takes the spotlight!
Vivek Subbiah shared a post on his LinkedIn page: "Hot off the press- Friday Motivation!…
Dec 4, 2023, 15:53 |
Blog
Sendurai Mani: Reflecting on a Memorable Year of Wonderful Interactions with Friends and Colleagues in Providence and at Brown University
Sendurai Mani, Associate Director for Translational Oncology at Brown University Legorreta Cancer Center, shared on…
Dec 2, 2023, 16:50 |
Positive
Mara Antonoff: When your famous friends come back to visit their humble beginnings
Mara Antonoff, Associate Professor of Thoracic and Cardiovascular Surgery at MD Anderson Cancer Center, shared…
Dec 1, 2023, 19:13 |
Insight
V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal
V. Lokesh Battula, Associate Professor at MD Anderson Cancer Center, shared on LinkedIn: "Happy to…
Nov 29, 2023, 16:31 |
Drugs
Vivek Subbiah: Our review on management of FGFR inhibitor toxicities
Vivek Subbiah shared on LinkedIn: "Pleased to share our review on management of FGFR inhibitor…
Nov 28, 2023, 16:43 |
Drugs
Vivek Subbiah: Pleased to share our review on RET inhibitors
Vivek Subbiah shared on LinkedIn: "Pleased to share our review on RET inhibitors and RET inhibitor…
Nov 23, 2023, 16:25 |
Blog
Ishwaria Subbiah: This is Equity In Action!
Ishwaria Subbiah recently shared on LinkedIn: "This is Equity In Action! Congrats, Navneet Majhail, Rocky Billups,…
131
132
133
134
135
All:
1454
Posts:
1321 - 1330
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO24: 20 Posts Not To Miss From Day 1
Fran Drescher and Uterine Cancer: How She Went Against, How She Survived, and More
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube